Search

This project is a randomized control trial (RCT) among people working in low-wage, precarious retail jobs to evaluate the impact of a new form of online organizing – facilitated discussion groups – on physical and emotional well-being, as well as workplace engagement. Using a customized version of the mobile app WorkIt, developed as a resource for low-wage workers by the non-profit organization United for Respect, the researchers will test the relative effect of assignment to a facilitated, small discussion group compared to assignment to an unmoderated community space.

To describe the results of a structured literature review of real-world outcomes with ixekizumab in patients with psoriasis (PsO) and/or psoriatic arthritis (PsA). Literature databases, conference proceedings and additional sources were searched for relevant publications. Real-world studies of ≥25 ixekizumab-treated patients with PsO and/or PsA were included. Data on clinical effectiveness, treatment persistence/patterns, economic outcomes, patient-reported outcomes (PROs) and safety were extracted. Fifty-one publications were included. Most studies focused on patients with PsO, and the number of publications with a focus on PROs was low. Studies of treatment patterns found that in general, ixekizumab had similar or better persistence versus other biologics, and rates or risk of switching similar to or less than comparator drugs. Adherence to ixekizumab was high, and patients were less likely to discontinue ixekizumab than other biologics. Ixekizumab was effective in the real world, with a safety profile consistent with that reported in clinical trials. Real-world use of ixekizumab in PsO and PsA is effective and safe, with generally high treatment persistence and adherence. Further work is required to determine the impact of ixekizumab on PROs in PsO, and to gather more data on real-world use of ixekizumab in PsA.

Supplemental material, sj-pdf-1-pun-10.1177_14624745211025751 for Criminogenic risk assessment: A meta-review and critical analysis by Seth J Prins and Adam Reich in Punishment & Society

Supplemental material, sj-pdf-2-lup-10.1177_09612033211016098 for Clinical characteristics of itch in cutaneous lupus erythematosus: A prospective, multicenter, multinational, cross-sectional study by Dominik Samotij, Justyna Szczęch, Emiliano Antiga, Diletta Bonciani, Marzia Caproni, François Chasset, Aleksandra Dańczak-Pazdrowska, Fukumi Furukawa, Minoru Hasegawa, Hideo Hashizume, Takaharu Ikeda, Aminul Islam, Hee Joo Kim, Aleksandra Lesiak, Laurent Misery, Mohammad Rafiqul Mowla, Adriana Polańska, Jacek C Szepietowski, Daisuke Tsuruta, Alice Verdelli, Victoria P Werth and Adam Reich in Lupus

Supplemental material, sj-pdf-1-lup-10.1177_09612033211016098 for Clinical characteristics of itch in cutaneous lupus erythematosus: A prospective, multicenter, multinational, cross-sectional study by Dominik Samotij, Justyna Szczęch, Emiliano Antiga, Diletta Bonciani, Marzia Caproni, François Chasset, Aleksandra Dańczak-Pazdrowska, Fukumi Furukawa, Minoru Hasegawa, Hideo Hashizume, Takaharu Ikeda, Aminul Islam, Hee Joo Kim, Aleksandra Lesiak, Laurent Misery, Mohammad Rafiqul Mowla, Adriana Polańska, Jacek C Szepietowski, Daisuke Tsuruta, Alice Verdelli, Victoria P Werth and Adam Reich in Lupus

Supplemental material, sj-pdf-1-pun-10.1177_14624745211025751 for Criminogenic risk assessment: A meta-review and critical analysis by Seth J Prins and Adam Reich in Punishment & Society

Supplemental material, sj-pdf-2-lup-10.1177_09612033211016098 for Clinical characteristics of itch in cutaneous lupus erythematosus: A prospective, multicenter, multinational, cross-sectional study by Dominik Samotij, Justyna Szczęch, Emiliano Antiga, Diletta Bonciani, Marzia Caproni, François Chasset, Aleksandra Dańczak-Pazdrowska, Fukumi Furukawa, Minoru Hasegawa, Hideo Hashizume, Takaharu Ikeda, Aminul Islam, Hee Joo Kim, Aleksandra Lesiak, Laurent Misery, Mohammad Rafiqul Mowla, Adriana Polańska, Jacek C Szepietowski, Daisuke Tsuruta, Alice Verdelli, Victoria P Werth and Adam Reich in Lupus